Business

RAD202 Phase 1 HEAT Trial Advances to Dose Level 3

RAD202 Phase 1 HEAT Trial Advances to Dose Level 3

Radiopharm Theranostics LimitedApril 7, 20264
RAD202 Phase 1 HEAT Trial Advances to Dose Level 3

About this update from Radiopharm Theranostics Limited

Radiopharm Theranostics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Radiopharm Theranostics Limited

More from Radiopharm Theranostics Limited

All Radiopharm Theranostics Limited news →